The use of LHRH agonists and antagonists in the treatment of myomata

P. Vercellini; B. Zaina; L. Trespidi; G. Stellato; S. Vicentini; A. Pisacreta

The use of LHRH agonists and antagonists in the treatment of myomata

P. Vercellini, B. Zaina, L. Trespidi, G. Stellato, S. Vicentini, A. Pisacreta

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article › peer-review

Abstract

In women with fibriods, luteinizing hormone-releasing hormone (LHRH) agonists help to correct menorrhagia-associated anemia, reducing the need for blood transfusions and emergency surgery. Long-term treatments with add-back therapies are feasible but should be limited to selected patients. Gonadotropin-releasing hormone agonists may facilitate hysteroscopic myomectomy especially in the presence of intramural tumors. Only preliminary data are available on LHRH antagonists used alone or in combination with surgery, and the practical relevance of avoidance of the flare-up phase in women with fibroids remains to be determined.

Original language	English
Pages (from-to)	195-214
Number of pages	20
Journal	Infertility and Reproductive Medicine Clinics of North America
Volume	12
Issue number	1
Publication status	Published - 2001

ASJC Scopus subject areas

Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'The use of LHRH agonists and antagonists in the treatment of myomata'. Together they form a unique fingerprint.

Cite this

@article{b82c26d034a24f38976d0689f932d68c,

title = "The use of LHRH agonists and antagonists in the treatment of myomata",

abstract = "In women with fibriods, luteinizing hormone-releasing hormone (LHRH) agonists help to correct menorrhagia-associated anemia, reducing the need for blood transfusions and emergency surgery. Long-term treatments with add-back therapies are feasible but should be limited to selected patients. Gonadotropin-releasing hormone agonists may facilitate hysteroscopic myomectomy especially in the presence of intramural tumors. Only preliminary data are available on LHRH antagonists used alone or in combination with surgery, and the practical relevance of avoidance of the flare-up phase in women with fibroids remains to be determined.",

author = "P. Vercellini and B. Zaina and L. Trespidi and G. Stellato and S. Vicentini and A. Pisacreta",

year = "2001",

language = "English",

volume = "12",

pages = "195--214",

journal = "Infertility and Reproductive Medicine Clinics of North America",

issn = "1047-9422",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - The use of LHRH agonists and antagonists in the treatment of myomata

AU - Vercellini, P.

AU - Zaina, B.

AU - Trespidi, L.

AU - Stellato, G.

AU - Vicentini, S.

AU - Pisacreta, A.

PY - 2001

Y1 - 2001

N2 - In women with fibriods, luteinizing hormone-releasing hormone (LHRH) agonists help to correct menorrhagia-associated anemia, reducing the need for blood transfusions and emergency surgery. Long-term treatments with add-back therapies are feasible but should be limited to selected patients. Gonadotropin-releasing hormone agonists may facilitate hysteroscopic myomectomy especially in the presence of intramural tumors. Only preliminary data are available on LHRH antagonists used alone or in combination with surgery, and the practical relevance of avoidance of the flare-up phase in women with fibroids remains to be determined.

AB - In women with fibriods, luteinizing hormone-releasing hormone (LHRH) agonists help to correct menorrhagia-associated anemia, reducing the need for blood transfusions and emergency surgery. Long-term treatments with add-back therapies are feasible but should be limited to selected patients. Gonadotropin-releasing hormone agonists may facilitate hysteroscopic myomectomy especially in the presence of intramural tumors. Only preliminary data are available on LHRH antagonists used alone or in combination with surgery, and the practical relevance of avoidance of the flare-up phase in women with fibroids remains to be determined.

UR - http://www.scopus.com/inward/record.url?scp=0035176142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035176142&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035176142

VL - 12

SP - 195

EP - 214

JO - Infertility and Reproductive Medicine Clinics of North America

JF - Infertility and Reproductive Medicine Clinics of North America

SN - 1047-9422

IS - 1

ER -

The use of LHRH agonists and antagonists in the treatment of myomata

Abstract

ASJC Scopus subject areas

Other files and links

Cite this